Stay tuned to OnThePen.com for more updates and in-depth analysis on the latest developments in weight loss and diabetes treatments
In the post, well consider the impact of the new medication in terms of clinical performance and patient experience, cost and utilization
Epigenetics 8 , 730738, (2013)
It may be considered for patients with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition
Supporting the microbiome to naturally enhance GLP-1 activity represents a safe, sustainable, and systems-based strategy to promote metabolic wellness, weight balance, and optimal health.
More than one in eight patients reported being "completely free" from knee pain at the end of the trial, according to a press release from Lilly